High-risk human papillomavirus messenger RNA testing in physician- And self-collected specimens for cervical lesion detection in high-risk women, Kenya

Sexually Transmitted Diseases

Volumn 40, Issue 7, 2013, Pages 584-589

  Ting, Jie ^a   Mugo, Nelly ^b   Kwatampora, Jessie ^c   Hill, Craig ^d   Chitwa, Michael ^c   Patel, Suha ^e   Gakure, Hannah ^c   Kimani, Joshua ^c   Schoenbach, Victor J ^a   Poole, Charles ^a   Smith, Jennifer S ^a,f  

^a University of North Carolina at Chapel Hill   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Gen Probe Incorporated   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; BETHESDA CRITERIA; CANCER DIAGNOSIS; COLPOSCOPY; COMPARATIVE STUDY; CONDOM USE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; EDUCATIONAL STATUS; FEMALE; GROUPS BY AGE; GYNECOLOGICAL AND OBSTETRIC SAMPLING DEVICE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HIGH RISK HUMAN PAPILLOMAVIRUS MESSENGER RNA TESTING; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; KENYA; MAJOR CLINICAL STUDY; MYCOPLASMOSIS; NUCLEIC ACID AMPLIFICATION; PELVIC EXAMINATION; PHYSICIAN; PHYSICIAN COLLECTED SPECIMEN; PREDICTIVE VALUE; PREVALENCE; PROSTITUTION; RISK FACTOR; SELF CARE; SELF COLLECTED SPECIMEN; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; TISSUE SECTION; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; ADOLESCENT; CERVICAL INTRAEPITHELIAL NEOPLASIA; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MIDDLE AGED; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SEXUALLY TRANSMITTED DISEASES, VIRAL; STANDARDS; UTERINE CERVICAL NEOPLASMS; VAGINA SMEAR; VIROLOGY; YOUNG ADULT;

MESSENGER RNA; VIRUS DNA;

ADOLESCENT; ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HUMANS; KENYA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEX WORKERS; SEXUALLY TRANSMITTED DISEASES, VIRAL; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84888645948     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31828e5a91     Document Type: Article

References (25)

1. Gustafsson L, Pontén J, Zack M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8:755-763.
2. Nygard JF, Skare GB, Thoresen SO. The cervical cancer screening programme in Norway, 1992-2000: Changes in Pap smear coverage and incidence of cervical cancer. J Med Screen 2002; 9:86-91.
3. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ 2001; 79:954-962.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC Cancer Base no. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr. Accessed November 17, 2011.
5. Denny L, Kuhn L, Risi L, et al. Two-stage cervical cancer screening: An alternative for resource-poor settings. Obstet Gynecol 2000; 183:383-388.
6. Wright TC, Denny L, Kuhn L, et al. HPV DNA testing of selfcollected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000; 283:81-86.
7. Stewart DE, Gagliardi A, Johnston M, et al. Self-collected samples for testing of oncogenic human papillomavirus: A systematic review. J Obstet Gynaecol Can 2007;29:817-828.
8. Salmeron J, Lazcano-Ponce E, Lorincz A, et al. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico. Cancer Causes Control 2003; 14:505-512.
9. Zhao FH, Lewkowitz AK, Chen F, et al. Pooled analysis of a selfsampling HPV DNA test as a cervical cancer primary screening method. J Natl Cancer Inst 2012; 104:178-188.
10. Monsonego J, Hudgens MG, Zerat L, et al. Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid based cytology in primary cervical cancer screening (the FASE study). Int J Cancer 2011; 129:691-701.
11. Hologic Gen-probe APTIMA\ HPV assay [package insert]. San Diego, CA: Hologic Gen-Probe, 2008.
12. Rothman KJ, Greenland S, Lash T. Median unbiased estimates. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2008: 221, 255-256.
13. Moyer VA. on behalf of the U.S Preventive Services Task Force. Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med 2012; 156:880-890.
14. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1999; 10:37-48.
15. Knüppel S, Stang A. DAG program: Identifying minimal sufficient adjustment sets. Epidemiology 2010; 21:159.
16. Poole C. Low P-values or narrow confidence intervals: Which are more durable? Epidemiology 2001; 12:291-294.
17. Luchters S, Broeck D, Chersich M, et al. Association of HIV infection with distribution and viral load of HPV types in Kenya: A survey with 820 female sex workers. BMC Infect Dis 2010; 10:18.
18. Del Amo J, González C, Belda J, et al. Prevalence and risk factors of high-risk human papillomavirus in female sex workers in Spain: Differences by geographical origin. J Women Health 2009; 18:2057-2064.
19. Juarez-Figueroa LA, Wheeler CM, Uribe-Salas FJ, et al. Human papillomavirus: A highly prevalent sexually transmitted disease agent among female sex workers from Mexico City. Sex Transm Dis 2001; 28:125-130.
20. Kjaer SK, Svare EI, Worm AM, et al. Human papillomavirus infection in Danish female sex workers: Decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000; 27:438-445.
21. Depuydt CE, Leuridan E, Van Damme P, et al. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in Flanders. Gynecol Obstet Invest 2010; 70:273-280.
22. Noël JC, Fayt I, Romero Munoz MR, et al. High prevalence of highrisk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology. Arch Gynecol Obstet 2010; 282:503-505.
23. Biernat-Sudolska M, Szostek S, Rojek-Zakrzewska D, et al. Concomitant infections with human papillomavirus and various mycoplasma and ureaplasma species in women with abnormal cervical cytology. Adv Med Sci 2011; 56:299-303.
24. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39:207-215.
25. Petignat P, Faltin DL, Bruchim I, et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and metaanalysis. Gynecol Oncol 2007; 105:530-535.